BlackRock ETF Trust BlackRock Long-Term U.S. Equity ETF BELT 深 沪
已收盘 09-19 16:00:00 美东时间
33.533
+0.136
+0.41%
华盛通- 最 高33.533
- 今 开33.3975
- 成交量 56股
- 最 低 33.533
- 昨 收 33.3975
- 总市值 804.79万
- 52周最高 33.533
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 23.62
- 委 比 44.00%
- 总股本 24.00万
- 历史最高 33.533
- 量 比 0
- 振 幅 0.00%
- 历史最低 23.62
- 每 手 1
- 风险率 1.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease
Belite Bio Inc announced the completion of the Phase 3 DRAGON trial for Tinlarebant in treating Stargardt disease type 1 (STGD1). The trial enrolled 104 adolescent subjects across 11 jurisdictions with a 2:1 randomization. Top-line data is expected in Q4 2025, and Belite plans to file New Drug Applications in 1H 2026. Tinlarebant has received multiple designations, including Breakthrough Therapy and Orphan Drug status, and aims to address an unme...
09-12 12:00
Belite Bio to Participate in Three Upcoming Investor Conferences
Belite Bio, Inc. announced that its executive management team will participate in three upcoming investor conferences: the Cantor Global Healthcare Conference on September 5, 2025, at 8:00 am ET; the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 5:35 pm ET; and the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, at 8:00 am ET. Each presentation will be available via webcast under t...
08-27 12:00
Belite Bio Announces Registered Direct Offering of $15 Million
Belite Bio, Inc. has entered into a securities purchase agreement to sell 230,770 ADSs and warrants for $65 per ADS, raising $15 million in gross proceeds, with potential additional $15 million from warrant exercises. The offering is to a single large existing institutional shareholder and is expected to close on August 8, 2025. Proceeds will be used for working capital and general corporate purposes. Titan Partners Group is the sole placement ag...
08-07 12:00
Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference
Belite Bio, a clinical-stage drug development company focusing on novel therapeutics for degenerative retinal diseases, announced its participation in the H.C. Wainwright Annual Ophthalmology Virtual Conference on August 13, 2025. The event includes an on-demand corporate presentation at 7:00 am ET and a panel discussion on "Pivotal-Stage Assets for Retinal Disorders" at 11:00 am ET. Webcasts will be available on the company’s investor relations ...
08-06 12:00
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
Belite Bio, a clinical-stage drug development company, announced its executive team will participate in the BTIG Virtual Biotechnology Conference on July 29-30, 2025. The company focuses on novel therapeutics for degenerative retinal diseases, including STGD1 and Geographic Atrophy (GA), with its lead candidate, Tinlarebant, in Phase 3 and Phase 2/3 studies. For more information, visit its website or follow on social media. Media and investor rel...
07-23 12:00
Mastercard, PayPal Partner To Offer Consumers More Payment Control
Mastercard and PayPal have partnered to improve consumer choice and control during checkout by introducing One Credential, a single payment identifier that can be tailored to individual preferences. This will also support healthier financial practices for PayPal users and strengthen the companies' collaboration on payment solutions. Investors can gain exposure to Mastercard through BELT and IYG. MA shares are up 0.29% at $583.65 premarket.
06-04 18:48
Mastercard Taps Into 100 Million Crypto Users With MoonPay Partnership
Mastercard shares edge higher after unveiling global stablecoin payment partnership with MoonPay.
05-16 01:18
Mastercard Bets On Cross-Border Payments With $300 Million Corpay Deal
Mastercard and Corpay expand partnership to offer improved cross-border payment solutions, with Mastercard investing $300 million in Corpay's business.
04-30 00:49
Mastercard's 2030 Vision: A Future Without Passwords, Card Numbers
Mastercard plans to eliminate passwords and manual card entry for online shopping by 2030, using tokenization and biometric authentication for secure checkout.
2024-11-14 23:49
Mastercard Brings Same-Day Payouts To South African Merchants: Details
Mastercard announced that South Africa will be the first to benefit from real-time card payments, supporting economic growth and financial inclusion.
2024-10-09 23:38
